Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hcv Hiv'

Hcv Hiv published presentations and documents on DocSlides.

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

  • jovita
  • 18 Slides

Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...

HCV Assays: Impact on HCV Studies

HCV Assays: Impact on HCV Studies

  • blanko
  • 14 Slides

& . Update on HCV . blood bank protocol. . Ov...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

  • kittie-lecroy
  • 48 Slides

Mark Sulkowski, MD . Professor of Medicine. Medic...

Treatment with the second-generation HCV protease inhibitor

Treatment with the second-generation HCV protease inhibitor

  • conchita-marotz
  • 20 Slides

Results from SILEN-C1 in HCV genotype-1 treatment...

Role of harm reduction in HCV prevention in France: from r

Role of harm reduction in HCV prevention in France: from r

  • tatiana-dople
  • 14 Slides

Bruno Spire & Patrizia Carrieri. How to reduc...

Sofosbuvir + Ribavirin in HCV Genotype 1

Sofosbuvir + Ribavirin in HCV Genotype 1

  • pamella-moone
  • 9 Slides

NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...

Housing Choice Voucher Program

Housing Choice Voucher Program

  • phoebe-click
  • 21 Slides

LANDLORD BRIEFING. 2015. KHRA & HCV ~ Overvie...

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

  • pasty-toler
  • 0 Slides

ASTRAL-1. Phase 3. . Treatment. . Naïve & ...

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

  • celsa-spraggs
  • 0 Slides

C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...

HCV Screening and Linkage to Care

HCV Screening and Linkage to Care

  • alexa-scheidler
  • 0 Slides

Program in a Pharmacy Setting. Conveying . the Ur...

O nline census of drug consumption rooms as a setting to address HCV:

O nline census of drug consumption rooms as a setting to address HCV:

  • phoebe-click
  • 0 Slides

 . current practice and future capacity.. Vendul...

HCV infection in prison. From

HCV infection in prison. From

  • olivia-moreira
  • 0 Slides

individual. care to . viral. . eradication. . ...

Simplified HCV Therapy in 2018

Simplified HCV Therapy in 2018

  • phoebe-click
  • 0 Slides

This program is s. upported. by educational gran...

Is it possible? HCV Elimination

Is it possible? HCV Elimination

  • yoshiko-marsland
  • 0 Slides

Objectives. Define elimination as it relates to i...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • danika-pritchard
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]

Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]

  • danika-pritchard
  • 0 Slides

Strategies To Identify and Advance PWID HCV Patie...

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

  • danika-pritchard
  • 0 Slides

NIAID Retreatment. Phase . 2a . Treatment. . Exp...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • trish-goza
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

OraQuick HCV Rapid Test

OraQuick HCV Rapid Test

  • sherrill-nordquist
  • 0 Slides

How to Run the . Test . Overview. Background Pres...

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

  • briana-ranney
  • 11 Slides

Sofosbuvir + Ribavirin to Prevent Post-Transplan...

HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community

HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community

  • cheryl-pisano
  • 19 Slides

HepCare Europe No-one gets left behind: address...

HCV 2016 Alex Rodgers Hepatologist

HCV 2016 Alex Rodgers Hepatologist

  • radions
  • 26 Slides

. FMC. Disclosures. nil. Learning objectives/. t. ...

Treatment of Chronic HCV

Treatment of Chronic HCV

  • lam
  • 58 Slides

with Direct-Acting Antivirals (DAAs). www.hcvguide...

Economic Impact of Eliminating HCV

Economic Impact of Eliminating HCV

  • InLoveWithLife
  • 11 Slides

H. . Razavi. April 13, 2016. HCV Economic impact m...

Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA

Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA

  • WannabeRockstar
  • 10 Slides

seroconversion. and genetically linked HCV infect...

Aptima HCV RNA Qualitative Assay

Aptima HCV RNA Qualitative Assay

  • delilah
  • 34 Slides

Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 ...

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

  • desha
  • 30 Slides

mHCV Genotype II Key to symbols used Global Tra...

Revised 122012 HEPATITIS C VIRUS HCV Hepatitis means inflammation

Revised 122012 HEPATITIS C VIRUS HCV Hepatitis means inflammation

  • madeline
  • 2 Slides

Revised 12/2012 What are the symptoms of HCV infec...

Hepatitis C Virus HCV Infection Testing for Diagnosis31

Hepatitis C Virus HCV Infection Testing for Diagnosis31

  • joanne
  • 1 Slides

Conrmed Unconrmed Unconrmed ...

Hepatitis C Virus HCV

Hepatitis C Virus HCV

  • danya
  • 2 Slides

Infects 30,000 people in the U.S. each year. Over...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

  • sophia
  • 54 Slides

April 10. –14. , 2019. Vienna, Austria. Disclaim...

Sofosbuvir + Ribavirin in HCV Recurrence

Sofosbuvir + Ribavirin in HCV Recurrence

  • williams
  • 8 Slides

Following Liver Transplantation. Phase 2. Charlton...

% of Global HCV Seropositive Cases

% of Global HCV Seropositive Cases

  • faith
  • 20 Slides

Global epidemiology of hepatitis C virus infection...

NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne

NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne

  • candy
  • 7 Slides

Supervising Consultant: Dr K. . Rolfe. Update: Mar...

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

  • ahmir
  • 11 Slides

ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...

MM: HCV and Cirrhosis Patient Case

MM: HCV and Cirrhosis Patient Case

  • devin732
  • 39 Slides

Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...

HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*

HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*

  • jesse588
  • 1 Slides

Mandatory criteria: . Probability based sampling. ...

Daclatasvir

Daclatasvir

  • tatyana-admore
  • 9 Slides

. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...

Listening to the service user voice:

Listening to the service user voice:

  • danika-pritchard
  • 32 Slides

advantages for service delivery design . Magdale...

Treatment of Hepatitis C in patients with

Treatment of Hepatitis C in patients with

  • tatyana-admore
  • 31 Slides

thalassaemia. . Where . are we now?. Telaprevir ....

Copyright © 2024 DocSlides. All Rights Reserved